Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Unlimited Watchlists, Portfolios, Screeners, and other Barchart tools. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Arcturus Therapeutics Ltd (ARCT)

Arcturus Therapeutics Ltd (ARCT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Arcturus Therapeutics Ltd 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121 USA

P: 858-900-2660

Description:

Arcturus Therapeutics Ltd. is a preclinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of RNA medicines using proprietary lipid-mediated delivery system LUNAR(TM) and UNA Oligomer chemistry technologies. Arcturus Therapeutics Ltd, formerly known as Alcobra Ltd, is based in San Diego, CA.

Key Statistics

Overview:

Market Capitalization, $K 488,531
Enterprise Value, $K 181,141
Shares Outstanding, K 26,493
Annual Sales, $ 12,360 K
Annual Net Income, $ -203,670 K
Last Quarter Sales, $ 13,370 K
Last Quarter Net Income, $ -35,270 K
60-Month Beta 2.51
% of Insider Shareholders 12.20%
% of Institutional Shareholders 83.55%
Float, K 23,261
% Float 87.80%
Short Volume Ratio 0.61

Growth:

1-Year Return -50.92%
3-Year Return 71.23%
5-Year Return 110.17%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth -24.24%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.33 on 11/09/22
Next Earnings Date N/A
Earnings Per Share ttm -5.56
EPS Growth vs. Prev Qtr -62.20%
EPS Growth vs. Prev Year 35.12%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Next Ex-Dividends Date 01/04/13
Dividend Payable Date 01/15/13
Dividend Payout Ratio 0.00%
Most Recent Split 1-7 on 11/16/17

ARCT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -80.43%
Return-on-Assets % -42.96%
Profit Margin % -1,647.82
Net Margin % N/A
Debt/Equity 0.21
Price/Sales 36.90
Price/Cash Flow N/A
Price/Book 3.15
Book Value/Share 5.48
Interest Coverage -105.08
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar